EFFECT OF INDUCERS OF CYTOCHROME-P-450 ON THE METABOLISM OF [3-C-14]COUMARIN BY RAT HEPATIC MICROSOMES

被引:46
作者
PETERS, MMCG
WALTERS, DG
VANOMMEN, B
VANBLADEREN, PJ
LAKE, BG
机构
[1] AGR UNIV WAGENINGEN, DEPT TOXICOL, DE DREIJEN 12, 6703 BC WAGENINGEN, NETHERLANDS
[2] BRITISH IND BIOL RES ASSOC, CARSHALTON SM5 4DS, SURREY, ENGLAND
[3] TNO, CIVO, INST TOXICOL & NUTR, DEPT BIOL TOXICOL, 3700 AJ ZEIST, NETHERLANDS
关键词
D O I
10.3109/00498259109039490
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The metabolism of [3-C-14]coumarin has been studied in rat hepatic microsomes and with two purified cytochrome P-450 isoenzymes. 2. [3-C-14]Coumarin was converted by liver microsomes to several polar products including 3- and/or 5-hydroxycoumarin, o-hydroxyphenylacetic acid and a major unidentified novel coumarin metabolite. 3. [3-C-14]Coumarin was also converted to reactive metabolite(s) indicated by covalent binding to proteins, and by the depletion of reduced glutathione added to the microsomal incubations. 4. [3-C-14]Coumarin metabolism to polar and covalently bound metabolites by rat liver microsomes was induced by pretreatment with phenobarbitone, 3-methylcholanthrene, beta-naphthoflavone, Aroclor 1254 and isosafrole; but not by dexamethasone or nafenopin. 5. The profile of [3-C-14]coumarin metabolism to polar products was similar in control and pretreated liver microsomes and in incubations with purified cytochrome P450 IA1 and P450 IIB1 isoenzymes. 6. The results indicate that coumarin is a substrate for isoenzymes of the cytochrome P450 IA and P450 IIB subfamilies. The bioactivation of coumarin by rat hepatic microsomes is postulated to result in the formation of a coumarin 3,4-epoxide intermediate which may rearrange to 3-hydroxycoumarin, be further metabolized to a coumarin 3,4-dihydrodiol, or form a glutathione conjugate.
引用
收藏
页码:499 / 514
页数:16
相关论文
共 43 条
[21]  
LAKE BG, 1984, ARCH TOXICOL, P16
[22]  
Lake BG, 1987, BIOCH TOXICOLOGY PRA, P183
[23]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[24]   GENETIC-VARIATION BETWEEN MICE IN THEIR METABOLISM OF COUMARIN AND ITS DERIVATIVES [J].
LUSH, IE ;
ANDREWS, KM .
GENETICAL RESEARCH, 1978, 31 (02) :177-186
[25]   IDENTIFICATION OF THE HUMAN LIVER CYTOCHROME-P-450 RESPONSIBLE FOR COUMARIN 7-HYDROXYLASE ACTIVITY [J].
MILES, JS ;
MCLAREN, AW ;
FORRESTER, LM ;
GLANCEY, MJ ;
LANG, MA ;
WOLF, CR .
BIOCHEMICAL JOURNAL, 1990, 267 (02) :365-371
[26]   A RAPID, SIMPLE INVITRO SCREENING-TEST, USING [H-3] GLUTATHIONE AND L-[S-35]CYSTEINE AS TRAPPING AGENTS, TO DETECT REACTIVE INTERMEDIATES OF XENOBIOTICS [J].
MULDER, GJ ;
LE, CT .
TOXICOLOGY IN VITRO, 1988, 2 (03) :225-230
[27]   THE P450 GENE SUPERFAMILY - RECOMMENDED NOMENCLATURE [J].
NEBERT, DW ;
ADESNIK, M ;
COON, MJ ;
ESTABROOK, RW ;
GONZALEZ, FJ ;
GUENGERICH, FP ;
GUNSALUS, IC ;
JOHNSON, EF ;
KEMPER, B ;
LEVIN, W ;
PHILLIPS, IR ;
SATO, R ;
WATERMAN, MR .
DNA-A JOURNAL OF MOLECULAR & CELLULAR BIOLOGY, 1987, 6 (01) :1-11
[28]  
NORMAN RL, 1984, DRUG METAB DISPOS, V12, P543
[29]   MONOGRAPHS ON FRAGRANCE RAW-MATERIALS [J].
OPDYKE, DLJ .
FOOD AND COSMETICS TOXICOLOGY, 1974, 12 (03) :385-405
[30]   COUMARIN 7-HYDROXYLASE ACTIVITY IN HUMAN-LIVER MICROSOMES - PROPERTIES OF THE ENZYME AND INTERSPECIES COMPARISONS [J].
PELKONEN, O ;
SOTANIEMI, EA ;
AHOKAS, JT .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 19 (01) :59-66